Global Kidney Transplant Market, by Type (Living Donor Transplant, Paired Kidney Transplant, and Deceased Donor Transplant), by Age (Children and Adults), by End Users (Hospitals & Clinics and Transplant Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 81,037 in 2021 and is expected to exhibit a CAGR of 3.1% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.
Key players operating in the market are focusing on receiving approvals and launches from regulatory authorities and this is expected to drive the market growth over the forecast period.
For instance, in September 2021, Sanofi, a global biopharmaceutical company focused on human health, entered into agreement with Kadmon Holdings, Inc., a biopharmaceutical organization that develops, and discovers the market transformative therapies. It supports Sanofi’s strategy to rise its core assets of general medicines.
Global Kidney Transplant Market – Impact of Coronavirus (Covid-19) Pandemic
COVID-19 outbreak was first reported on December 31, 2019, in Wuhan, China. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 260 million cases and 5.2 million deaths due to Coronavirus (COVID-19) were reported up till November 29, 2021, across the globe.
During COVID-19 pandemic, as per studies, decrease in transplant activity in all countries was noticed. As per compared to lung, liver, and heart transplantation, the kidney transplantation was most affected. The three organ transplant rate patterns identified were: countries with a sharp decrease in transplantation rate with a low COVID-19 related death rate; countries with a moderate decrease in transplantation rate with a moderate COVID-19 related death rate; and countries with a slight decrease in transplantation rate despite a high COVID-19 related death rate. The reduction in transplant activity was marked during the first three months of pandemic with losses after June 2020, and also reducing again in October to December, 2020.
Browse 20 Market Data Tables and 35 Figures spread through 195 Pages and in-depth TOC on “Kidney Transplant Market”- Global Forecast to 2028, by Type (Living Donor Transplant, Paired Kidney Transplant, and Deceased Donor Transplant), by Age (Children and Adults), by End Users (Hospitals & Clinics and Transplant Centers), and by Regions (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in this market, click the link below:
Key players operating in the market are focusing on adoption of inorganic growth strategies such as mergers, approvals, collaborations, and acquisitions in order to strengthen their position in the global market. For instance, in April 2021, the U.S. FDA approved Farxiga (Dapagliflozin) to decrease the chances of kidney function decline, kidney failure, and hospitalization for heart failure in adults with chronic kidney disease.
Key Takeaways of the Global Kidney Transplant Market